{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:43:29Z","timestamp":1786167809191,"version":"build-2736575974"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Cuban Ministry of Science, Technology, and Environment through the National Program of Neurosciences and Neurotechnology","award":["PN305LH013-034"],"award-info":[{"award-number":["PN305LH013-034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-026-02050-x","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:35:22Z","timestamp":1783643722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune Activation and Glial Dysfunction in Spinocerebellar Ataxias: From Cerebellar Landscape to Disease-Driven Mechanisms and Immunomodulation"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5994-4562","authenticated-orcid":false,"given":"Yaime\u00e9","family":"V\u00e1zquez-Mojena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3193-7683","authenticated-orcid":false,"given":"Roberto","family":"Rodr\u00edguez-Labrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1628-2703","authenticated-orcid":false,"given":"Luis","family":"Vel\u00e1zquez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2050_CR1","doi-asserted-by":"publisher","unstructured":"Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Prim [Internet]. 2019;5:24. Available from: https:\/\/doi.org\/10.1038\/s41572-019-0074-3","DOI":"10.1038\/s41572-019-0074-3"},{"key":"2050_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00415-018-9076-4","volume":"266","author":"R Sullivan","year":"2019","unstructured":"Sullivan R, Yau WY, O\u2019connor E, Houlden H. Spinocerebellar ataxia: an update. J Neurol. 2019;266:533\u201344.","journal-title":"J Neurol"},{"key":"2050_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-012-1000-x","volume":"124","author":"K Seidel","year":"2012","unstructured":"Seidel K, Siswanto S, Brunt ERP. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012;124:1\u201321.","journal-title":"Acta Neuropathol"},{"key":"2050_CR4","doi-asserted-by":"crossref","unstructured":"Paulson HL, Shakkottai VG, Clark HB, Orr HT. Polyglutamine spinocerebellar ataxias \u2014 from genes to potential treatments. Nat Rev Neurosci [Internet]. 2017;18:613\u201326. Available from: https:\/\/www.nature.com\/articles\/nrn.2017.92","DOI":"10.1038\/nrn.2017.92"},{"key":"2050_CR5","doi-asserted-by":"publisher","unstructured":"Matilla-Due\u00f1as A, Ashizawa T, Brice A, Magri S, McFarland KN, Pandolfo M et al. Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. The Cerebellum [Internet]. 2014;13:269\u2013302. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12311-013-0539-y","DOI":"10.1007\/s12311-013-0539-y"},{"key":"2050_CR6","doi-asserted-by":"crossref","unstructured":"N\u00f3brega C, Marcelo A, Rajado AT, Concei\u00e7\u00e3o A, Estevam B, Matos CA et al. Molecular hallmarks of neurodegeneration in polyglutamine spinocerebellar ataxias. Cell Death Dis [Internet]. 2025;16:826. Available from: https:\/\/www.nature.com\/articles\/s41419-025-08154-2","DOI":"10.1038\/s41419-025-08154-2"},{"key":"2050_CR7","doi-asserted-by":"publisher","unstructured":"Buijsen RAM, Toonen LJA, Gardiner SL, van Roon-Mom WMC. Genetics, mechanisms, and therapeutic progress in polyglutamine spinocerebellar ataxias. Neurotherapeutics [Internet]. 2019;16:263\u201386. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s13311-018-00696-y","DOI":"10.1007\/s13311-018-00696-y"},{"key":"2050_CR8","doi-asserted-by":"publisher","unstructured":"Meera P, Pulst SM, Otis TS. Cellular and circuit mechanisms underlying spinocerebellar ataxias. J Physiol [Internet]. 2016;594:4653\u201360. Available from: https:\/\/physoc.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1113\/JP271897","DOI":"10.1113\/JP271897"},{"key":"2050_CR9","first-page":"6","volume":"07","author":"S Mikhailova","year":"2024","unstructured":"Mikhailova S. Neuroinflammation: The Silent Culprit behind a Range of Neurological Disorders. J Clin Neurol Neurosurg. 2024;07:6\u20137.","journal-title":"J Clin Neurol Neurosurg"},{"key":"2050_CR10","doi-asserted-by":"publisher","unstructured":"Hayashide L, de Pessoa S, Dias B, Pontes G, Pinto B, Diniz RS. LP. From neuron-centric to glia\u2010centric: how aging glial networks drive neurodegenerative disease. J Neurochem [Internet]. 2026;170:1\u201318. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/jnc.70361","DOI":"10.1111\/jnc.70361"},{"key":"2050_CR11","doi-asserted-by":"crossref","unstructured":"Ajoolabady A, Kim B, Abdulkhaliq AA, Ren J, Bahijri S, Tuomilehto J et al. Dual role of microglia in neuroinflammation and neurodegenerative diseases. Neurobiol Dis [Internet]. 2025;216:107133. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999612500350X","DOI":"10.1016\/j.nbd.2025.107133"},{"key":"2050_CR12","doi-asserted-by":"publisher","unstructured":"DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. J Neurochem [Internet]. 2016;139:136\u201353. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/jnc.13607","DOI":"10.1111\/jnc.13607"},{"key":"2050_CR13","doi-asserted-by":"publisher","unstructured":"Urrestizala-Arenaza N, Cerchio S, Cavaliere F, Magliaro C. Limitations of human brain organoids to study neurodegenerative diseases: a manual to survive. Front Cell Neurosci [Internet]. 2024;18. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fncel.2024.1419526\/full","DOI":"10.3389\/fncel.2024.1419526\/full"},{"key":"2050_CR14","doi-asserted-by":"publisher","unstructured":"Warden AS, Han C, Hansen E, Trescott S, Nguyen C, Kim R et al. Tools for studying human microglia: In vitro and in vivo strategies. Brain Behav Immun [Internet]. 2023;107:369\u201382. Available from: https:\/\/doi.org\/10.1016\/j.bbi.2022.10.008","DOI":"10.1016\/j.bbi.2022.10.008"},{"key":"2050_CR15","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.4103\/NRR.NRR-D-24-01539","volume":"21","author":"K Li","year":"2026","unstructured":"Li K, Chen R, Wang R, Fan W, Zhao N, Yang Z, et al. Neuroinflammation in neurodegenerative diseases: Focusing on the mediation of T lymphocytes. Neural Regen Res. 2026;21:1864\u201389.","journal-title":"Neural Regen Res"},{"key":"2050_CR16","doi-asserted-by":"crossref","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther [Internet]. 2023;8:267. Available from: https:\/\/www.nature.com\/articles\/s41392-023-01486-5","DOI":"10.1038\/s41392-023-01486-5"},{"key":"2050_CR17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000548021","volume":"32","author":"KM Alem\u00e1n-Villa","year":"2025","unstructured":"Alem\u00e1n-Villa KM, Armienta-Rojas DA, Camberos-Barraza J, R\u00e1bago-Monz\u00f3n \u00c1R, Camacho-Zamora A, Osuna-Ramos JF, et al. Neuroinflammation across the Spectrum of Neurodegenerative Diseases: Mechanisms and Therapeutic Frontiers. Neuroimmunomodulation. 2025;32:278\u2013305.","journal-title":"Neuroimmunomodulation"},{"key":"2050_CR18","doi-asserted-by":"crossref","unstructured":"Vishnumukkala T, Che Mohd Nassir CMN, Hein ZM, Kalerammana Gopalakrishna P, Karikalan B, Alkatiri A et al. Glial cells as emerging therapeutic targets in neurodegenerative diseases: mechanistic insights and translational perspectives. Cells [Internet]. 2025;14:1497. Available from: https:\/\/www.mdpi.com\/2073-4409\/14\/19\/1497","DOI":"10.3390\/cells14191497"},{"key":"2050_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pneurobio.2013.01.001","volume":"104","author":"U R\u00fcb","year":"2013","unstructured":"R\u00fcb U, Sch\u00f6ls L, Paulson H, Auburger G, Kermer P, Jen JC, et al. Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog Neurobiol. 2013;104:38\u201366.","journal-title":"Prog Neurobiol"},{"key":"2050_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s13311-023-01357-5","volume":"20","author":"M Cvetanovic","year":"2023","unstructured":"Cvetanovic M, Gray M. Contribution of Glial Cells to Polyglutamine Diseases: Observations from Patients and Mouse Models. Neurotherapeutics. 2023;20:48\u201366.","journal-title":"Neurotherapeutics"},{"key":"2050_CR21","doi-asserted-by":"publisher","unstructured":"Salas IH, Alfonso-Triguero M, D\u00edaz Castro B, Elazar N, Escartin C, Akl CF et al. Astrocytes as therapeutic targets in neurodegenerative disorders. J Neurosci [Internet]. 2025;45:e1379252025. Available from: https:\/\/www.jneurosci.org\/lookup\/doi\/https:\/\/doi.org\/10.1523\/JNEUROSCI.1379-25.2025","DOI":"10.1523\/JNEUROSCI.1379-25.2025"},{"key":"2050_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci. 2024;16:1\u201316.","journal-title":"Front Aging Neurosci"},{"key":"2050_CR23","doi-asserted-by":"crossref","unstructured":"Ruiz-Rodr\u00edguez VM, Cuellar-Santoyo AO, Estrada-S\u00e1nchez AM. Advances in how the peripheral immune system interacts with the brain in health and disease. Neuroscience [Internet]. 2026;596:24\u201335. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225012266","DOI":"10.1016\/j.neuroscience.2025.12.059"},{"key":"2050_CR24","doi-asserted-by":"publisher","unstructured":"Verkhratsky A, Ho MS, Zorec R, Parpura V. neuroglia in neurodegenerative diseases [Internet]. Verkhratsky A, Ho MS, Zorec R, Parpura V, editors. Singapore: Springer Singapore; 2019. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-981-13-9913-8_1","DOI":"10.1007\/978-981-13-9913-8_1"},{"key":"2050_CR25","doi-asserted-by":"publisher","unstructured":"Afridi R, Kim J-H, Rahman MH, Suk K. Metabolic regulation of glial phenotypes: implications in neuron\u2013glia interactions and neurological disorders. Front Cell Neurosci [Internet]. 2020;14:1\u201317. Available from: https:\/\/www.frontiersin.org\/article\/https:\/\/doi.org\/10.3389\/fncel.2020.00020\/full","DOI":"10.3389\/fncel.2020.00020\/full"},{"key":"2050_CR26","doi-asserted-by":"publisher","unstructured":"Batenburg KL, Scheper W. Neuron-to-astrocyte proteostatic stress signaling in response to tau pathology. Neural Regen Res [Internet]. 2024;19:505\u20136. Available from: https:\/\/journals.lww.com\/https:\/\/doi.org\/10.4103\/1673-5374.377609","DOI":"10.4103\/1673-5374.377609"},{"key":"2050_CR27","doi-asserted-by":"publisher","unstructured":"Han S, Gim Y, Jang E-H, Hur E-M. Functions and dysfunctions of oligodendrocytes in neurodegenerative diseases. Front Cell Neurosci [Internet]. 2022;16:1\u201312. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fncel.2022.1083159","DOI":"10.3389\/fncel.2022.1083159"},{"key":"2050_CR28","doi-asserted-by":"crossref","unstructured":"Kokkosis AG, Madeira MM, Mullahy MR, Tsirka SE. Chronic stress disrupts the homeostasis and progeny progression of oligodendroglial lineage cells, associating immune oligodendrocytes with prefrontal cortex hypomyelination. Mol Psychiatry [Internet]. 2022;27:2833\u201348. Available from: https:\/\/www.nature.com\/articles\/s41380-022-01512-y","DOI":"10.1038\/s41380-022-01512-y"},{"key":"2050_CR29","doi-asserted-by":"publisher","unstructured":"Klegeris A. Regulation of neuroimmune processes by damage- and resolution-associated molecular patterns. Neural Regen Res [Internet]. 2021;16:423\u20139. Available from: https:\/\/journals.lww.com\/https:\/\/doi.org\/10.4103\/1673-5374.293134","DOI":"10.4103\/1673-5374.293134"},{"key":"2050_CR30","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B, et al. Microglia states and nomenclature: A field at its crossroads. Neuron. 2022;110:3458\u201383.","journal-title":"Neuron"},{"key":"2050_CR31","doi-asserted-by":"publisher","unstructured":"Su CA, Baldwin WM, Fairchild RL. Soluble mediators in the immune system. Transpl Immunol [Internet]. Wiley; 2015. pp. 48\u201364. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/9781119072997.ch3","DOI":"10.1002\/9781119072997.ch3"},{"key":"2050_CR32","doi-asserted-by":"crossref","unstructured":"Satapathy T, Patel N, Sahu P, Satapathy A. Decoding inflammatory signaling networks: From molecular mechanisms to therapeutic targets. Adv Biomark Sci Technol [Internet]. 2025;7:204\u201321. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2543106425000146","DOI":"10.1016\/j.abst.2025.07.002"},{"key":"2050_CR33","doi-asserted-by":"publisher","unstructured":"Han RT, Kim RD, Molofsky AV, Liddelow SA. Astrocyte-immune cell interactions in physiology and pathology. Immunity [Internet]. 2021;54:211\u201324. Available from: https:\/\/doi.org\/10.1016\/j.immuni.2021.01.013","DOI":"10.1016\/j.immuni.2021.01.013"},{"key":"2050_CR34","doi-asserted-by":"crossref","unstructured":"Chang NP, DaPrano EM, Lindman M, Estevez I, Chou T-W, Evans WR et al. Neuronal DAMPs exacerbate neurodegeneration via astrocytic RIPK3 signaling. JCI Insight [Internet]. 2024;9:1\u201320. Available from: https:\/\/insight.jci.org\/articles\/view\/177002","DOI":"10.1172\/jci.insight.177002"},{"key":"2050_CR35","doi-asserted-by":"crossref","unstructured":"Colombo E, Farina C, Astrocytes. Key regulators of neuroinflammation. Trends Immunol [Internet]. 2016;37:608\u201320. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490616300722","DOI":"10.1016\/j.it.2016.06.006"},{"key":"2050_CR36","doi-asserted-by":"crossref","unstructured":"Pandey S, Shen K, Lee S-H, Shen Y-AA, Wang Y, Otero-Garc\u00eda M et al. Disease-associated oligodendrocyte responses across neurodegenerative diseases. Cell Rep [Internet]. 2022;40:111189. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124722010063","DOI":"10.1016\/j.celrep.2022.111189"},{"key":"2050_CR37","doi-asserted-by":"crossref","unstructured":"Lin ML, Lin W. Oligodendrocytes are active participants in the pathogenesis of multiple sclerosis and its animal models. Int J Mol Sci [Internet]. 2026;27:1779. Available from: https:\/\/www.mdpi.com\/1422-0067\/27\/4\/1779","DOI":"10.3390\/ijms27041779"},{"key":"2050_CR38","doi-asserted-by":"publisher","unstructured":"Gruol DL. The neuroimmune system and the cerebellum. Cerebellum [Internet]. 2024;23:2511\u201337. Available from: https:\/\/doi.org\/10.1007\/s12311-023-01624-3","DOI":"10.1007\/s12311-023-01624-3"},{"key":"2050_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms26157553","volume":"26","author":"G La Sala","year":"2025","unstructured":"La Sala G, Farini D. Glial Cells and Aging: From the CNS to the Cerebellum. Int J Mol Sci. 2025;26:1\u201337.","journal-title":"Int J Mol Sci"},{"key":"2050_CR40","doi-asserted-by":"publisher","unstructured":"Depp C, Doman JL, Hingerl M, Xia J, Stevens B. Microglia transcriptional states and their functional significance: Context drives diversity. Immunity [Internet]. 2025;58:1052\u201367. Available from: https:\/\/doi.org\/10.1016\/j.immuni.2025.04.009","DOI":"10.1016\/j.immuni.2025.04.009"},{"key":"2050_CR41","doi-asserted-by":"crossref","unstructured":"Grabert K, Michoel T, Karavolos MH, Clohisey S, Baillie JK, Stevens MP et al. Microglial brain region\u2013dependent diversity and selective regional sensitivities to aging. Nat Neurosci [Internet]. 2016;19:504\u201316. Available from: https:\/\/www.nature.com\/articles\/nn.4222","DOI":"10.1038\/nn.4222"},{"key":"2050_CR42","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nn.4547","volume":"20","author":"TL Tay","year":"2017","unstructured":"Tay TL, Mai D, Dautzenberg J, Fern\u00e1ndez-Klett F, Lin G, Sagar S, et al. A new fate mapping system reveals context-dependent random or clonal expansion of microglia. Nat Neurosci. 2017;20:793\u2013803.","journal-title":"Nat Neurosci"},{"key":"2050_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","volume":"39","author":"LJ Lawson","year":"1990","unstructured":"Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 1990;39:151\u201370.","journal-title":"Neuroscience"},{"key":"2050_CR44","doi-asserted-by":"publisher","unstructured":"Ayata P, Badimon A, Strasburger HJ, Duff MK, Montgomery SE, Loh YHE et al. Epigenetic regulation of brain region-specific microglia clearance activity. Nat Neurosci [Internet]. 2018;21:1049\u201360. Available from: https:\/\/doi.org\/10.1038\/s41593-018-0192-3","DOI":"10.1038\/s41593-018-0192-3"},{"key":"2050_CR45","doi-asserted-by":"publisher","unstructured":"Woodruff-Pak DS, Foy MR, Akopian GG, Lee KH, Zach J, Nguyen KPT et al. Differential effects and rates of normal aging in cerebellum and hippocampus. Proc Natl Acad Sci [Internet]. 2010;107:1624\u20139. Available from: https:\/\/doi.org\/10.1073\/pnas.0914207107","DOI":"10.1073\/pnas.0914207107"},{"key":"2050_CR46","doi-asserted-by":"publisher","unstructured":"Yamamoto M, Kim M, Imai H, Itakura Y, Ohtsuki G. Microglia-triggered plasticity of intrinsic excitability modulates psychomotor behaviors in acute cerebellar inflammation. Cell Rep [Internet]. 2019;28:2923\u20132938.e8. Available from: https:\/\/doi.org\/10.1016\/j.celrep.2019.07.078","DOI":"10.1016\/j.celrep.2019.07.078"},{"key":"2050_CR47","doi-asserted-by":"crossref","unstructured":"Shim HG, Jang S-S, Kim SH, Hwang EM, Min JO, Kim HY et al. TNF-\u03b1 increases the intrinsic excitability of cerebellar Purkinje cells through elevating glutamate release in Bergmann Glia. Sci Rep [Internet]. 2018;8:11589. Available from: https:\/\/www.nature.com\/articles\/s41598-018-29786-9","DOI":"10.1038\/s41598-018-29786-9"},{"key":"2050_CR48","doi-asserted-by":"publisher","unstructured":"Yasuda T, Uchiyama T, Watanabe N, Ito N, Nakabayashi K, Mochizuki H et al. Peripheral immune system modulates Purkinje cell degeneration in Niemann-Pick disease type C1. Life Sci Alliance [Internet]. 2023;6:e202201881. Available from: https:\/\/www.life-science-alliance.org\/lookup\/doi\/https:\/\/doi.org\/10.26508\/lsa.202201881","DOI":"10.26508\/lsa.202201881"},{"key":"2050_CR49","doi-asserted-by":"publisher","unstructured":"Kavetsky L, Green KK, Boyle BR, Yousufzai FAK, Padron ZM, Melli SE et al. Increased interactions and engulfment of dendrites by microglia precede Purkinje cell degeneration in a mouse model of Niemann Pick Type-C. Sci Rep [Internet]. 2019;9:14722. Available from: https:\/\/doi.org\/10.1038\/s41598-019-51246-1","DOI":"10.1038\/s41598-019-51246-1"},{"key":"2050_CR50","doi-asserted-by":"publisher","unstructured":"Plum T, Feyerabend TB, Rodewald H-R. Beyond classical immunity: Mast cells as signal converters between tissues and neurons. Immunity [Internet]. 2024;57:2723\u201336. Available from: https:\/\/doi.org\/10.1016\/j.immuni.2024.11.016","DOI":"10.1016\/j.immuni.2024.11.016"},{"key":"2050_CR51","doi-asserted-by":"publisher","unstructured":"Kim HY, Kim S, Akaydin AN, Kim S, Hyeon SJ, Lee J et al. The rise of astrocytes: are they guardians or troublemakers of the brain disorder? Exp Mol Med [Internet]. 2026;58:301\u201318. Available from: https:\/\/doi.org\/10.1038\/s12276-025-01627-6","DOI":"10.1038\/s12276-025-01627-6"},{"key":"2050_CR52","doi-asserted-by":"publisher","unstructured":"Liddelow SA, Barres BA. Reactive astrocytes: production, function, and therapeutic potential. Immunity [Internet]. 2017;46:957\u201367. Available from: https:\/\/doi.org\/10.1016\/j.immuni.2017.06.006","DOI":"10.1016\/j.immuni.2017.06.006"},{"key":"2050_CR53","doi-asserted-by":"publisher","unstructured":"Fan Y-Y, Huo J. A1\/A2 astrocytes in central nervous system injuries and diseases: Angels or devils? Neurochem Int [Internet]. 2021;148:105080. Available from: https:\/\/doi.org\/10.1016\/j.neuint.2021.105080","DOI":"10.1016\/j.neuint.2021.105080"},{"key":"2050_CR54","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1002\/alz.13678","volume":"20","author":"P Edison","year":"2024","unstructured":"Edison P. Astroglial activation: Current concepts and future directions. Alzheimer\u2019s Dement. 2024;20:3034\u201353.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2050_CR55","unstructured":"Escartin C, Galea E, Lakatos A, O\u2019Callaghan JP, Petzold GC, Serrano-Pozo A et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci [Internet]. 2021;24:312\u201325. Available from: https:\/\/www.nature.com\/articles\/s41593-020-00783-4"},{"key":"2050_CR56","doi-asserted-by":"publisher","unstructured":"Cerrato V. Cerebellar astrocytes: Much more than passive bystanders in ataxia pathophysiology. J Clin Med. 2020;9(3):757. https:\/\/doi.org\/10.3390\/jcm9030757","DOI":"10.3390\/jcm9030757"},{"key":"2050_CR57","doi-asserted-by":"publisher","unstructured":"Buffo A, Rossi F. Origin, lineage and function of cerebellar glia. Prog Neurobiol [Internet]. 2013;109:42\u201363. Available from: https:\/\/doi.org\/10.1016\/j.pneurobio.2013.08.001","DOI":"10.1016\/j.pneurobio.2013.08.001"},{"key":"2050_CR58","doi-asserted-by":"publisher","unstructured":"Boisvert MM, Erikson GA, Shokhirev MN, Allen NJ. The aging astrocyte transcriptome from multiple regions of the mouse brain. Cell Rep [Internet]. 2018;22:269\u201385. Available from: https:\/\/doi.org\/10.1016\/j.celrep.2017.12.039","DOI":"10.1016\/j.celrep.2017.12.039"},{"key":"2050_CR59","doi-asserted-by":"crossref","unstructured":"Sotelo C. Cerebellar neuroglia: morphological and histochemical aspects. in: fox ca, snider rs, editors. Prog Brain Res [Internet]. Elsevier; 1967. pp. 226\u201350. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612308609668","DOI":"10.1016\/S0079-6123(08)60966-8"},{"key":"2050_CR60","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s12311-019-01046-0","volume":"18","author":"APB Araujo","year":"2019","unstructured":"Araujo APB, Carpi-Santos R, Gomes FCA. The Role of Astrocytes in the Development of the Cerebellum. Cerebellum. 2019;18:1017\u201335.","journal-title":"Cerebellum"},{"key":"2050_CR61","doi-asserted-by":"publisher","unstructured":"De Zeeuw CI, Hoogland TM. Reappraisal of Bergmann glial cells as modulators of cerebellar circuit function. Front Cell Neurosci [Internet]. 2015;9. Available from: http:\/\/journal.frontiersin.org\/Article\/https:\/\/doi.org\/10.3389\/fncel.2015.00246\/abstract","DOI":"10.3389\/fncel.2015.00246\/abstract"},{"key":"2050_CR62","doi-asserted-by":"publisher","unstructured":"Mohebiany AN, Schneider R. Glutamate excitotoxicity in the cerebellum mediated by IL-1\u03b2. J Neurosci [Internet]. 2013;33:18353\u20135. Available from: https:\/\/www.jneurosci.org\/lookup\/doi\/https:\/\/doi.org\/10.1523\/JNEUROSCI.3946-13.2013","DOI":"10.1523\/JNEUROSCI.3946-13.2013"},{"key":"2050_CR63","doi-asserted-by":"publisher","unstructured":"Chrobak AA, Soltys Z, Bergmann Glia L-T. Depression, and autism spectrum disorder. Mol Neurobiol [Internet]. 2017;54:1156\u201366. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12035-016-9719-3","DOI":"10.1007\/s12035-016-9719-3"},{"key":"2050_CR64","doi-asserted-by":"publisher","unstructured":"Power EM, Empson RM. Functional contributions of glutamate transporters at the parallel fibre to Purkinje neuron synapse\u2013relevance for the progression of cerebellar ataxia. Cerebellum & Ataxias [Internet]. 2014;1:3. Available from: https:\/\/cerebellumandataxias.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/2053-8871-1-3","DOI":"10.1186\/2053-8871-1-3"},{"key":"2050_CR65","doi-asserted-by":"publisher","unstructured":"Pasquini JM, Correale JD. The immunological role of oligodendrocytes: beyond myelin maintenance. Discov Immunol [Internet]. 2025;4. Available from: https:\/\/academic.oup.com\/discovimmunology\/article\/doi\/https:\/\/doi.org\/10.1093\/discim\/kyaf005\/8121173","DOI":"10.1093\/discim\/kyaf005\/8121173"},{"key":"2050_CR66","doi-asserted-by":"publisher","unstructured":"Mecklenburg N, Garcia-L\u00f3pez R, Puelles E, Sotelo C, Martinez S. Cerebellar oligodendroglial cells have a mesencephalic origin. Glia [Internet]. 2011;59:1946\u201357. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/glia.21236","DOI":"10.1002\/glia.21236"},{"key":"2050_CR67","doi-asserted-by":"publisher","unstructured":"Hashimoto R, Hori K, Owa T, Miyashita S, Dewa K, Masuyama N et al. Origins of oligodendrocytes in the cerebellum, whose development is controlled by the transcription factor, Sox9. Mech Dev [Internet]. 2016;140:25\u201340. Available from: https:\/\/doi.org\/10.1016\/j.mod.2016.02.004","DOI":"10.1016\/j.mod.2016.02.004"},{"key":"2050_CR68","doi-asserted-by":"publisher","unstructured":"Barron T, Saifetiarova J, Bhat MA, Kim JH. Myelination of Purkinje axons is critical for resilient synaptic transmission in the deep cerebellar nucleus. Sci Rep [Internet]. 2018;8:1022. Available from: https:\/\/doi.org\/10.1038\/s41598-018-19314-0","DOI":"10.1038\/s41598-018-19314-0"},{"key":"2050_CR69","doi-asserted-by":"publisher","unstructured":"Collin L, Usiello A, Erbs E, Mathis C, Borrelli E. Motor training compensates for cerebellar dysfunctions caused by oligodendrocyte ablation. Proc Natl Acad Sci [Internet]. 2004;101:325\u201330. Available from: https:\/\/doi.org\/10.1073\/pnas.0305994101","DOI":"10.1073\/pnas.0305994101"},{"key":"2050_CR70","doi-asserted-by":"publisher","unstructured":"Xie S-T, Fan W-C, Zhao X-S, Ma X-Y, Li Z-L, Zhao Y-R et al. Proinflammatory activation of microglia in the cerebellum hyperexcites Purkinje cells to trigger ataxia. Pharmacol Res [Internet]. 2023;191:106773. Available from: https:\/\/doi.org\/10.1016\/j.phrs.2023.106773","DOI":"10.1016\/j.phrs.2023.106773"},{"key":"2050_CR71","doi-asserted-by":"publisher","unstructured":"Bahaaeldin M, B\u00fclte C, Luelsberg F, Kumar S, Kappler J, V\u00f6lker C et al. Engrailed-2 and inflammation convergently and independently impinge on cerebellar Purkinje cell differentiation. J Neuroinflammation [Internet]. 2024;21:306. Available from: https:\/\/doi.org\/10.1186\/s12974-024-03301-6","DOI":"10.1186\/s12974-024-03301-6"},{"key":"2050_CR72","doi-asserted-by":"crossref","unstructured":"French RA, VanHoy RW, Chizzonite R, Zachary JF, Dantzer R, Parnet P et al. Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice. J Neuroimmunol [Internet]. 1999;93:194\u2013202. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572898002240","DOI":"10.1016\/S0165-5728(98)00224-0"},{"key":"2050_CR73","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.4049\/jimmunol.180.4.2322","volume":"180","author":"T Andoh","year":"2008","unstructured":"Andoh T, Kishi H, Motoki K, Nakanishi K, Kuraishi Y, Muraguchi A. Protective Effect of IL-18 on Kainate- and IL-1\u03b2-Induced Cerebellar Ataxia in Mice. J Immunol. 2008;180:2322\u20138.","journal-title":"J Immunol"},{"key":"2050_CR74","doi-asserted-by":"publisher","unstructured":"Motoki K, Kishi H, Hori E, Tajiri K, Nishijo H, Muraguchi A. The direct excitatory effect of IL-1\u03b2 on cerebellar Purkinje cell. Biochem Biophys Res Commun [Internet]. 2009;379:665\u20138. Available from: https:\/\/doi.org\/10.1016\/j.bbrc.2008.12.023","DOI":"10.1016\/j.bbrc.2008.12.023"},{"key":"2050_CR75","doi-asserted-by":"publisher","unstructured":"Mandolesi G, Musella A, Gentile A, Grasselli G, Haji N, Sepman H et al. Interleukin-1 alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis. J Neurosci [Internet]. 2013;33:12105\u201321. Available from: https:\/\/www.jneurosci.org\/lookup\/doi\/https:\/\/doi.org\/10.1523\/JNEUROSCI.5369-12.2013","DOI":"10.1523\/JNEUROSCI.5369-12.2013"},{"key":"2050_CR76","doi-asserted-by":"publisher","unstructured":"Nelson TE, Ur CL, Gruol DL. Chronic interleukin-6 exposure alters electrophysiological properties and calcium signaling in developing cerebellar purkinje neurons in culture. J Neurophysiol [Internet]. 2002;88:475\u201386. Available from: https:\/\/www.physiology.org\/doi\/https:\/\/doi.org\/10.1152\/jn.2002.88.1.475","DOI":"10.1152\/jn.2002.88.1.475"},{"key":"2050_CR77","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1111\/j.1460-9568.2004.03706.x","volume":"20","author":"TE Nelson","year":"2004","unstructured":"Nelson TE, Netzeband JG, Gruol DL. Chronic interleukin-6 exposure alters metabotropic glutamate receptor-activated calcium signalling in cerebellar Purkinje neurons. Eur J Neurosci. 2004;20:2387\u2013400.","journal-title":"Eur J Neurosci"},{"key":"2050_CR78","doi-asserted-by":"publisher","unstructured":"Gruol D, Nelson T. Purkinje neuron physiology is altered by the inflammatory factor interleukin-6. The Cerebellum [Internet]. 2005;4:198\u2013205. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1080\/14734220500199987","DOI":"10.1080\/14734220500199987"},{"key":"2050_CR79","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1111\/j.1460-9568.2005.04113.x","volume":"21","author":"KLI Van Gassen","year":"2005","unstructured":"Van Gassen KLI, Netzeband JG, De Graan PNE, Gruol DL. The chemokine CCL2 modulates Ca2\u2009+\u2009dynamics and electrophysiological properties of cultured cerebellar Purkinje neurons. Eur J Neurosci. 2005;21:2949\u201357.","journal-title":"Eur J Neurosci"},{"key":"2050_CR80","doi-asserted-by":"crossref","unstructured":"Giovannelli A, Limatola C, Ragozzino D, Mileo AM, Ruggieri A, Ciotti MT et al. CXC chemokines interleukin-8 (IL-8) and growth-related gene product \u03b1 (GRO\u03b1) modulate Purkinje neuron activity in mouse cerebellum. J Neuroimmunol [Internet]. 1998;92:122\u201332. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572898001921","DOI":"10.1016\/S0165-5728(98)00192-1"},{"key":"2050_CR81","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1046\/j.1460-9568.2000.00139.x","volume":"12","author":"C Limatola","year":"2000","unstructured":"Limatola C, Giovannelli A, Maggi L, Ragozzino D, Castellani L, Ciotti MT, et al. SDF-1\u03b1-mediated modulation of synaptic transmission in rat cerebellum. Eur J Neurosci. 2000;12:2497\u2013504.","journal-title":"Eur J Neurosci"},{"key":"2050_CR82","doi-asserted-by":"publisher","unstructured":"Zhu J, Li Y, Wang Z, Jia W, Xu R. Toll-like receptor 4 deficiency impairs motor coordination. Front Neurosci [Internet]. 2016;10:1\u201310. Available from: http:\/\/journal.frontiersin.org\/Article\/https:\/\/doi.org\/10.3389\/fnins.2016.00033\/abstract","DOI":"10.3389\/fnins.2016.00033\/abstract"},{"key":"2050_CR83","doi-asserted-by":"publisher","unstructured":"Zhu J, Qiu W, Wei F, Zhang J, Yuan Y, Liu L et al. Toll-like receptor 4 deficiency in Purkinje neurons drives cerebellar ataxia by impairing the BK channel-mediated after-hyperpolarization and cytosolic calcium homeostasis. Cell Death Dis [Internet]. 2024;15:594. Available from: https:\/\/doi.org\/10.1038\/s41419-024-06988-w","DOI":"10.1038\/s41419-024-06988-w"},{"key":"2050_CR84","doi-asserted-by":"crossref","unstructured":"Yang K, Dunn M, Torres-Ramirez G, Dobbs N, Shakkottai VG, Yan N. Autonomous STING signaling in Purkinje cells drives neurodegeneration independent of type I interferon. Cell Rep [Internet]. 2025;44:116480. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725012513","DOI":"10.1016\/j.celrep.2025.116480"},{"key":"2050_CR85","doi-asserted-by":"publisher","unstructured":"Zhang Y, Zou M, Wu H, Zhu J, Jin T. The cGAS-STING pathway drives neuroinflammation and neurodegeneration via cellular and molecular mechanisms in neurodegenerative diseases. Neurobiol Dis [Internet]. 2024;202:106710. Available from: https:\/\/doi.org\/10.1016\/j.nbd.2024.106710","DOI":"10.1016\/j.nbd.2024.106710"},{"key":"2050_CR86","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neuroscience.2015.01.003","volume":"289","author":"M Cvetanovic","year":"2015","unstructured":"Cvetanovic M, Ingram M, Orr H, Opal P. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1. Neuroscience. 2015;289:289\u201399.","journal-title":"Neuroscience"},{"key":"2050_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0200013","volume":"13","author":"A Ferro","year":"2018","unstructured":"Ferro A, Qu W, Lukowicz A, Svedberg D, Johnson A, Cvetanovic M. Inhibition of NF-\u03baB signaling in IKK\u03b2F\/F;LysM Cre mice causes motor deficits but does not alter pathogenesis of Spinocerebellar ataxia type 1. PLoS ONE. 2018;13:1\u201321.","journal-title":"PLoS ONE"},{"key":"2050_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-0880-z","volume":"14","author":"W Qu","year":"2017","unstructured":"Qu W, Johnson A, Kim JH, Lukowicz A, Svedberg D, Cvetanovic M. Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice. J Neuroinflammation. 2017;14:1\u201311.","journal-title":"J Neuroinflammation"},{"key":"2050_CR89","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/glia.23451","volume":"66","author":"JH Kim","year":"2018","unstructured":"Kim JH, Lukowicz A, Qu W, Johnson A, Cvetanovic M. Astroglia contribute to the pathogenesis of spinocerebellar ataxia Type 1 (SCA1) in a biphasic, stage-of-disease specific manner. Glia. 2018;66:1972\u201387.","journal-title":"Glia"},{"key":"2050_CR90","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1523\/JNEUROSCI.5612-09.2010","volume":"30","author":"G \u00d6z","year":"2010","unstructured":"\u00d6z G, Nelson CD, Koski DM, Henry PG, Marja\u0144ska M, Deelchand DK, et al. Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1. J Neurosci. 2010;30:3831\u20138.","journal-title":"J Neurosci"},{"key":"2050_CR91","unstructured":"Vig PJS, Lopez ME, Wei J, D\u2019Souza DR, Subramony S, Henegar J et al. Glial S100B positive vacuoles in purkinje cells: earliest morphological abnormality in sca1 transgenic mice. J Neurol Sci Turk [Internet]. 2006;23:166\u201374. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender"},{"key":"2050_CR92","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12311-009-0125-5","volume":"8","author":"PJS Vig","year":"2009","unstructured":"Vig PJS, Shao Q, Subramony SH, Lopez ME, Safaya E. Bergmann glial S100B activates Myo-inositol monophosphatase 1 and Co-localizes to Purkinje cell vacuoles in SCA1 transgenic mice. Cerebellum. 2009;8:231\u201344.","journal-title":"Cerebellum"},{"key":"2050_CR93","doi-asserted-by":"crossref","unstructured":"Yang C, Gravendeel N, On AC, Post L, van Bergen R, Osorio C et al. Fingolimod prevents neuroinflammation but has a limited effect on the development of ataxia in a mouse model for SCA1. Int J Mol Sci [Internet]. 2025;26:4698. Available from: https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4698","DOI":"10.3390\/ijms26104698"},{"key":"2050_CR94","doi-asserted-by":"crossref","unstructured":"Belozor OS, Yakovleva DA, Potapenko IV, Shuvaev AN, Smolnikova MV, Vasilev A et al. Extracellular S100\u03b2 disrupts bergman glia morphology and synaptic transmission in cerebellar purkinje cells. Brain Sci [Internet]. 2019;9:80. Available from: https:\/\/www.mdpi.com\/2076-3425\/9\/4\/80","DOI":"10.3390\/brainsci9040080"},{"key":"2050_CR95","doi-asserted-by":"crossref","unstructured":"Rosa J, Hamel K, Sheeler C, Borgenheimer E, Gilliat S, Soles A et al. Spatial and temporal diversity of astrocyte phenotypes in spinocerebellar ataxia type 1 mice. Cells [Internet]. 2022;11:3323. Available from: https:\/\/www.mdpi.com\/2073-4409\/11\/20\/3323","DOI":"10.3390\/cells11203323"},{"key":"2050_CR96","doi-asserted-by":"publisher","unstructured":"Edamakanti CR, Mohan V, Opal P. Reactive Bergmann glia play a central role in spinocerebellar ataxia inflammation via the JNK pathway. J Neuroinflammation [Internet]. 2023;20:1\u201313. Available from: https:\/\/doi.org\/10.1186\/s12974-023-02801-1","DOI":"10.1186\/s12974-023-02801-1"},{"key":"2050_CR97","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1038\/emboj.2010.116","volume":"29","author":"H Shiwaku","year":"2010","unstructured":"Shiwaku H, Yoshimura N, Tamura T, Sone M, Ogishima S, Watase K, et al. Suppression of the novel ER protein Maxer by mutant ataxin-1 in Bergman glia contributes to non-cell-autonomous toxicity. EMBO J. 2010;29:2446\u201360.","journal-title":"EMBO J"},{"key":"2050_CR98","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1017\/S1740925X08000185","volume":"3","author":"R Giovannoni","year":"2007","unstructured":"Giovannoni R, Maggio N, Rosaria Bianco M, Cavaliere C, Cirillo G, Lavitrano M, et al. Reactive astrocytosis and glial glutamate transporter clustering are early changes in a spinocerebellar ataxia type 1 transgenic mouse model. Neuron Glia Biol. 2007;3:335\u201351.","journal-title":"Neuron Glia Biol"},{"key":"2050_CR99","doi-asserted-by":"publisher","unstructured":"Vig PJS, Hearst S, Shao Q, Lopez ME, Murphy HA, Safaya E. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: trtk12 peptide, a potential candidate for sca1 therapy. The Cerebellum [Internet]. 2011;10:254\u201366. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12311-011-0262-5","DOI":"10.1007\/s12311-011-0262-5"},{"key":"2050_CR100","doi-asserted-by":"publisher","unstructured":"\u00d6z G, Hutter D, Tk\u00e1\u010d I, Clark HB, Gross MD, Jiang H et al. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Mov Disord [Internet]. 2010;25:1253\u201361. Available from: https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/mds.23067","DOI":"10.1002\/mds.23067"},{"key":"2050_CR101","doi-asserted-by":"crossref","unstructured":"Shiwaku H, Yagishita S, Eishi Y, Okazawa H. Bergmann glia are reduced in spinocerebellar ataxia type 1. Neuroreport [Internet]. 2013;24:620\u20135. Available from: https:\/\/journals.lww.com\/00001756-201308070-00008","DOI":"10.1097\/WNR.0b013e32836347b7"},{"key":"2050_CR102","doi-asserted-by":"crossref","unstructured":"Scoles DR, Dansithong W, Pflieger LT, Paul S, Gandelman M, Figueroa KP et al. ALS-associated genes in SCA2 mouse spinal cord transcriptomes. Hum Mol Genet [Internet]. 2020;29:1658\u201372. Available from: https:\/\/academic.oup.com\/hmg\/article\/29\/10\/1658\/5822587","DOI":"10.1093\/hmg\/ddaa072"},{"key":"2050_CR103","doi-asserted-by":"crossref","unstructured":"Vieira de S\u00e1 R, Sudria-Lopez E, Ca\u00f1izares Luna M, Harschnitz O, van den Heuvel DMA, Kling S et al. ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes. Nat Commun [Internet]. 2024;15:7484. Available from: https:\/\/www.nature.com\/articles\/s41467-024-51676-0","DOI":"10.1038\/s41467-024-51676-0"},{"key":"2050_CR104","doi-asserted-by":"publisher","unstructured":"Kim S, Sharma C, Hong J, Kim JH, Nam Y, Kim MS et al. Post-symptomatic administration of hMSCs exerts therapeutic effects in SCA2 mice. Stem Cell Res Ther [Internet]. 2024;15. Available from: https:\/\/doi.org\/10.1186\/s13287-024-04020-8","DOI":"10.1186\/s13287-024-04020-8"},{"key":"2050_CR105","doi-asserted-by":"publisher","unstructured":"Park SM, Kim SS, Cho E, Lee GB, Lee JM, Kim DW et al. Therapeutic targeting of blood-derived protein infiltration to modulate neuroinflammation in cerebellar ataxia. J Neuroinflammation [Internet]. 2026;23:168. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1186\/s12974-026-03811-5","DOI":"10.1186\/s12974-026-03811-5"},{"key":"2050_CR106","doi-asserted-by":"crossref","unstructured":"Canet-Pons J, Sen N, Arsovi\u0107 A, Almaguer-Mederos L-E, Halbach MV, Key J et al. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression. Neurobiol Dis [Internet]. 2021;152:105289. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996121000383","DOI":"10.1016\/j.nbd.2021.105289"},{"key":"2050_CR107","doi-asserted-by":"publisher","unstructured":"Sen N-E, von Bernhardi JE, Adeyemi JO, Arsovi\u0107 A, Canet-Pons J, Miralles AJ et al. ATXN2 polyglutamine expansion impairs QKI-dependent alternative splicing and oligodendrocyte maintenance. bioarvix [Internet]. 2025;4:1\u201383. Available from: http:\/\/biorxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2025.08.08.669189","DOI":"10.1101\/2025.08.08.669189"},{"key":"2050_CR108","doi-asserted-by":"publisher","unstructured":"Auburger G, Kandi AR, Vutukuri R, Almaguer-Mederos R, Gispert S, Sen N-E et al. Astro-versus microglia-enriched transcriptomes from aged atxn2-cag100-knockin mice suggest underlying pathology of rna processing at ribosomes, and possibly at u-bodies. Cells. 2026;15(8):699. https:\/\/doi.org\/10.3390\/cells15080699","DOI":"10.3390\/cells15080699"},{"key":"2050_CR109","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.3390\/ijms20235854","volume":"20","author":"NE Sen","year":"2019","unstructured":"Sen NE, Arsovic A, Meierhofer D, Brodesser S, Oberschmidt C, Canet-Pons J, et al. In human and mouse spino-cerebellar tissue, ataxin-2 expansion affects ceramide-sphingomyelin metabolism. Int J Mol Sci. 2019;20:5854.","journal-title":"Int J Mol Sci"},{"key":"2050_CR110","doi-asserted-by":"publisher","unstructured":"R\u00fcb U, Gierga K, Brunt ER, de Vos RAI, Bauer M, Sch\u00f6ls L et al. Spinocerebellar ataxias types 2 and 3: degeneration of the precerebellar nuclei isolates the three phylogenetically defined regions of the cerebellum. J Neural Transm [Internet]. 2005;112:1523\u201345. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00702-005-0287-3","DOI":"10.1007\/s00702-005-0287-3"},{"key":"2050_CR111","doi-asserted-by":"publisher","unstructured":"R\u00fcb U, Brunt ER, Petrasch-Parwez E, Sch\u00f6ls L, Theegarten D, Auburger G et al. Degeneration of ingestion\u2010related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7. Neuropathol Appl Neurobiol [Internet]. 2006;32:635\u201349. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/j.1365-2990.2006.00772.x","DOI":"10.1111\/j.1365-2990.2006.00772.x"},{"key":"2050_CR112","doi-asserted-by":"publisher","unstructured":"Hoche F, Seidel K, Brunt ER, Auburger G, Sch\u00f6ls L, B\u00fcrk K et al. Involvement of the auditory brainstem system in spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7). Neuropathol Appl Neurobiol [Internet]. 2008;34:479\u201391. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00933.x","DOI":"10.1111\/j.1365-2990.2007.00933.x"},{"key":"2050_CR113","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1093\/brain\/awg234","volume":"126","author":"U Rub","year":"2003","unstructured":"Rub U, Del Turco D, Del Tredici K, de Vos RAI, Brunt ER, Schultz GRCS, Auburger C, Braak G. Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance. Brain. 2003;126:2257\u201372.","journal-title":"Brain"},{"key":"2050_CR114","doi-asserted-by":"publisher","unstructured":"Gierga K, B\u00fcrk K, Bauer M, Orozco Diaz G, Auburger G, Schultz C et al. Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2). Acta Neuropathol [Internet]. 2005;109:617\u201331. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00401-005-1014-8","DOI":"10.1007\/s00401-005-1014-8"},{"key":"2050_CR115","doi-asserted-by":"publisher","unstructured":"\u00d6z G, Iltis I, Hutter D, Thomas W, Bushara KO, Gomez CM. Distinct Neurochemical Profiles of Spinocerebellar Ataxias 1, 2, 6, and Cerebellar Multiple System Atrophy. The Cerebellum [Internet]. 2011;10:208\u201317. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12311-010-0213-6","DOI":"10.1007\/s12311-010-0213-6"},{"key":"2050_CR116","doi-asserted-by":"publisher","unstructured":"Joers JM, Deelchand DK, Lyu T, Emir UE, Hutter D, Gomez CM et al. Neurochemical abnormalities in premanifest and early spinocerebellar ataxias. Ann Neurol [Internet]. 2018;83:816\u201329. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/ana.25212","DOI":"10.1002\/ana.25212"},{"key":"2050_CR117","doi-asserted-by":"publisher","unstructured":"Adanyeguh IM, Henry P, Nguyen TM, Rinaldi D, Jauffret C, Valabregue R et al. In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7. Mov Disord [Internet]. 2015;30:662\u201370. Available from: https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/mds.26181","DOI":"10.1002\/mds.26181"},{"key":"2050_CR118","doi-asserted-by":"publisher","unstructured":"Joers JM, Wei Y, Deelchand DK, Berrington A, Park YW, Banan G et al. Neurochemical endpoints to inform early-stage trials of spinocerebellar ataxia 2 and 3 in a multisite setting. Ann Clin Transl Neurol [Internet]. 2026; Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/acn3.70443","DOI":"10.1002\/acn3.70443"},{"key":"2050_CR119","doi-asserted-by":"crossref","unstructured":"Brouillette AM, \u00d6z G, Gomez CM. Cerebrospinal fluid biomarkers in spinocerebellar ataxia: a pilot study. Dis Markers [Internet]. 2015;2015:1\u20136. Available from: http:\/\/www.hindawi.com\/journals\/dm\/2015\/413098\/","DOI":"10.1155\/2015\/413098"},{"key":"2050_CR120","doi-asserted-by":"publisher","unstructured":"V\u00e1zquez-Mojena Y, Rodr\u00edguez\u2010C\u00f3rdova Y, Dominguez\u2010Barrios Y, Le\u00f3n\u2010Arcia K, Miranda\u2010Becerra D, Gonzalez\u2010Zaldivar Y et al. Peripheral inflammation links with the severity of clinical phenotype in spinocerebellar ataxia 2. Mov Disord [Internet]. 2023;38:880\u20135. Available from: https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/mds.29359","DOI":"10.1002\/mds.29359"},{"key":"2050_CR121","doi-asserted-by":"publisher","unstructured":"V\u00e1zquez-Mojena Y, Rodr\u00edguez-Labrada R, C\u00f3rdova-Rodr\u00edguez Y, Dom\u00ednguez-Barrios Y, Fern\u00e1ndez-Herrera ME, Le\u00f3n-Arcia K et al. Serum S100\u03b2 levels are linked with cognitive decline and peripheral inflammation in spinocerebellar ataxia type 2. The Cerebellum [Internet]. 2024;23:1509\u201320. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12311-024-01665-2","DOI":"10.1007\/s12311-024-01665-2"},{"key":"2050_CR122","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12311-025-01917-9","volume":"24","author":"Y V\u00e1zquez-Mojena","year":"2025","unstructured":"V\u00e1zquez-Mojena Y, Rodr\u00edguez-Labrada R, C\u00f3rdova-Rodr\u00edguez Y, Dom\u00ednguez-Barrios Y, Zamora-Loyarte DI, Fern\u00e1ndez-Herrera ME, et al. Elevated Interleukin-8 in Spinocerebellar Ataxia Type 2: A Distinct Peripheral Immune Signature Unrelated To Disease Severity. Cerebellum. 2025;24:165.","journal-title":"Cerebellum"},{"key":"2050_CR123","doi-asserted-by":"publisher","unstructured":"V\u00e1zquez-Mojena Y, Rodr\u00edguez-Labrada R, Mart\u00ednez Mart\u00ed L, Horruitiner Guti\u00e9rrez I, C\u00f3rdova-Rodr\u00edguez Y, Zamora-Fung R et al. Peripheral lymphocyte subsets in spinocerebellar Ataxia type 2: Insights into disease mechanisms and potential immunomodulation. J Neuroimmunol. 2026;417:578940. https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578940","DOI":"10.1016\/j.jneuroim.2026.578940"},{"key":"2050_CR124","doi-asserted-by":"crossref","unstructured":"Ashraf NS, Sutton JR, Yang Y, Ranxhi B, Libohova K, Shaw ED et al. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein. Neurobiol Dis [Internet]. 2020;137:104697. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119303729","DOI":"10.1016\/j.nbd.2019.104697"},{"key":"2050_CR125","first-page":"1","volume":"22","author":"Y Lin","year":"2021","unstructured":"Lin Y, Te, Lin YS, Cheng WL, Chang JC, Chao YC, Liu CS, et al. Transcriptomic and metabolic network analysis of metabolic reprogramming and igf-1 modulation in sca3 transgenic mice. Int J Mol Sci. 2021;22:1\u201319.","journal-title":"Int J Mol Sci"},{"key":"2050_CR126","doi-asserted-by":"publisher","unstructured":"Li Z, Du X, Yang Y, Zhang L, Chen P, Kan Y et al. Treatment of neurological pathology and inflammation in Machado\u2013Joseph disease through in vivo self-assembled siRNA. Brain [Internet]. 2025;148:817\u201332. Available from: https:\/\/doi.org\/10.1093\/brain\/awae304","DOI":"10.1093\/brain\/awae304"},{"key":"2050_CR127","doi-asserted-by":"publisher","unstructured":"Schuster KH, Zalon AJ, Zhang H, DiFranco DM, Stec NR, Haque Z et al. Impaired oligodendrocyte maturation is an early feature in sca3 disease pathogenesis. J Neurosci [Internet]. 2022;42:1604\u201317. Available from: https:\/\/www.jneurosci.org\/lookup\/doi\/https:\/\/doi.org\/10.1523\/JNEUROSCI.1954-20.2021","DOI":"10.1523\/JNEUROSCI.1954-20.2021"},{"key":"2050_CR128","doi-asserted-by":"crossref","unstructured":"Campos AB, Duarte-Silva S, Fernandes B, das Neves SP, Marques F, Teixeira-Castro A et al. Profiling microglia in a mouse model of machado\u2013joseph disease. Biomedicines [Internet]. 2022;10:237. Available from: https:\/\/www.mdpi.com\/2227-9059\/10\/2\/237","DOI":"10.3390\/biomedicines10020237"},{"key":"2050_CR129","doi-asserted-by":"crossref","unstructured":"Campos AB, Duarte-Silva S, Fernandes B, Coimbra B, Campos J, Monteiro-Fernandes D et al. Microglial depletion has no impact on disease progression in a mouse model of machado\u2013joseph disease. Cells [Internet]. 2022;11:2022. Available from: https:\/\/www.mdpi.com\/ 2073-4409\/11\/13\/2022.","DOI":"10.3390\/cells11132022"},{"key":"2050_CR130","doi-asserted-by":"crossref","unstructured":"Silva-Fernandes A, Duarte-Silva S, Neves-Carvalho A, Amorim M, Soares-Cunha C, Oliveira P et al. Chronic treatment with 17-dmag improves balance and coordination in a new mouse model of machado-joseph disease. Neurotherapeutics [Internet]. 2014;11:433\u201349. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923009108","DOI":"10.1007\/s13311-013-0255-9"},{"key":"2050_CR131","doi-asserted-by":"crossref","unstructured":"Cunha-Garcia D, Monteiro-Fernandes D, Correia JS, Neves-Carvalho A, Vila\u00e7a-Ferreira AC, Guerra-Gomes S et al. Genetic ablation of inositol 1,4,5-trisphosphate receptor type 2 (ip3r2) fails to modify disease progression in a mouse model of spinocerebellar ataxia type 3. Int J Mol Sci [Internet]. 2023;24:10606. Available from: https:\/\/www.mdpi.com\/1422-0067\/24\/13\/10606","DOI":"10.3390\/ijms241310606"},{"key":"2050_CR132","doi-asserted-by":"publisher","unstructured":"Sowa AS, Haas E, H\u00fcbener-Schmid J, Lorentz A. Ataxin-3, the spinocerebellar ataxia type 3 neurodegenerative disorder protein, affects mast cell functions. Front Immunol [Internet]. 2022;13:1\u201310. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2022.870966\/full","DOI":"10.3389\/fimmu.2022.870966\/full"},{"key":"2050_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1278-2","volume":"15","author":"YX Li","year":"2018","unstructured":"Li YX, Sibon OCM, Dijkers PF. Inhibition of NF-\u039aB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons. J Neuroinflammation. 2018;15:1\u201317.","journal-title":"J Neuroinflammation"},{"key":"2050_CR134","doi-asserted-by":"publisher","unstructured":"Evert BO, Vogt IR, Kindermann C, Ozimek L, De Vos RAI, Brunt ERP et al. Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J Neurosci. 2001;21(15):5389\u201396. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-15-05389.2001","DOI":"10.1523\/JNEUROSCI.21-15-05389.2001"},{"key":"2050_CR135","doi-asserted-by":"crossref","unstructured":"Chiu Y-J, Lin S-A, Chen W-L, Lin T-H, Lin C-H, Yao C-F et al. Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation. Aging (Albany NY) [Internet]. 2020;12:23619\u201346. Available from: https:\/\/www.mdpi.com\/1422-0067\/22\/3\/1062","DOI":"10.18632\/aging.103700"},{"key":"2050_CR136","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1111\/ene.15373","volume":"29","author":"H Garcia-Moreno","year":"2022","unstructured":"Garcia-Moreno H, Prudencio M, Thomas-Black G, Solanky N, Jansen-West KR, Hanna AL, Shaikh R, et al. Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3. Eur J Neurol. 2022;29:2439\u201352.","journal-title":"Eur J Neurol"},{"key":"2050_CR137","doi-asserted-by":"crossref","unstructured":"R\u00fcb U, de Vos RA, Brunt E, Schultz C, Paulson H, Del Tredici K et al. Degeneration of the external cuneate nucleus in spinocerebellar ataxia type 3 (Machado\u2013Joseph disease). Brain Res [Internet]. 2002;953:126\u201334. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000689930203278X","DOI":"10.1016\/S0006-8993(02)03278-X"},{"key":"2050_CR138","doi-asserted-by":"publisher","unstructured":"da Silva Carvalho G, Saute JAM, Haas CB, Torrez VR, Brochier AW, Souza GN et al. Cytokines in Machado Joseph Disease\/Spinocerebellar Ataxia 3. The Cerebellum [Internet]. 2016;15:518\u201325. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12311-015-0719-z","DOI":"10.1007\/s12311-015-0719-z"},{"key":"2050_CR139","unstructured":"Zhou J, Lei L, Shi Y, Wang J, Jiang H, Shen L et al. Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3\/Machado-Joseph disease. Zhong Nan Da Xue Xue Bao Yi Xue Ban [Internet]. 2011;36:504\u201310. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21743141"},{"key":"2050_CR140","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cccn.2004.08.010","volume":"351","author":"ABL Tort","year":"2005","unstructured":"Tort ABL, Portela LVC, Rockenbach IC, Monte TL, Pereira ML, Souza DO, et al. S100B and NSE serum concentrations in Machado Joseph disease. Clin Chim Acta. 2005;351:143\u20138.","journal-title":"Clin Chim Acta"},{"key":"2050_CR141","doi-asserted-by":"publisher","unstructured":"Zhang J-Y, Su Q-N, Lin H, Lin W, Cui M-L, Huang Z-Y et al. Peripheral inflammation in spinocerebellar ataxia type 3: associations with genetic and clinical manifestations. Inflamm Res [Internet]. 2025;74:137. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00011-025-02102-8","DOI":"10.1007\/s00011-025-02102-8"},{"key":"2050_CR142","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1093\/hmg\/ddv202","volume":"24","author":"T Aikawa","year":"2015","unstructured":"Aikawa T, Mogushi K, Iijima-Tsutsui K, Ishikawa K, Sakurai M, Tanaka H, et al. Loss of MyD88 alters neuroinflammatory response and attenuates early Purkinje cell loss in a spinocerebellar ataxia type 6 mouse model. Hum Mol Genet. 2015;24:4780\u201391.","journal-title":"Hum Mol Genet"},{"key":"2050_CR143","doi-asserted-by":"publisher","unstructured":"Gierga K, Schelhaas HJ, Brunt ER, Seidel K, Scherzed W, Egensperger R et al. Spinocerebellar ataxia type 6 (SCA6): neurodegeneration goes beyond the known brain predilection sites. Neuropathol Appl Neurobiol [Internet]. 2009;35:515\u201327. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/j.1365-2990.2009.01015.x","DOI":"10.1111\/j.1365-2990.2009.01015.x"},{"key":"2050_CR144","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0304-3940(01)01934-6","volume":"307","author":"M Nishimura","year":"2001","unstructured":"Nishimura M, Kawakami H, Maruyama H, Izumi Y, Kuno S, Kaji R, et al. Influence of interleukin-1\u03b2 gene polymorphism on age-at-onset of spinocerebellar ataxia 6 (SCA6) in Japanese patients. Neurosci Lett. 2001;307:128\u201330.","journal-title":"Neurosci Lett"},{"key":"2050_CR145","first-page":"1","volume":"14","author":"AF Fusco","year":"2021","unstructured":"Fusco AF, Pucci LA, Switonski PM, Biswas DD, McCall AL, Kahn AF, et al. Respiratory dysfunction in a mouse model of spinocerebellar ataxia type 7. DMM Dis Model Mech. 2021;14:1\u20139.","journal-title":"DMM Dis Model Mech"},{"key":"2050_CR146","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/nn1750","volume":"9","author":"SK Custer","year":"2006","unstructured":"Custer SK, Garden GA, Gill N, Rueb U, Libby RT, Schultz C, et al. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat Neurosci. 2006;9:1302\u201311.","journal-title":"Nat Neurosci"},{"key":"2050_CR147","doi-asserted-by":"publisher","unstructured":"Furrer SA, Mohanachandran MS, Waldherr SM, Chang C, Damian VA, Sopher BL et al. Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration. J Neurosci [Internet]. 2011;31:16269\u201378. Available from: https:\/\/www.jneurosci.org\/lookup\/doi\/https:\/\/doi.org\/10.1523\/JNEUROSCI.4000-11.2011","DOI":"10.1523\/JNEUROSCI.4000-11.2011"},{"key":"2050_CR148","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3390\/ijms27020683","volume":"27","author":"VM Borgonio-Cuadra","year":"2026","unstructured":"Borgonio-Cuadra VM, Meza-Dorantes A, Rodr\u00edguez-P\u00e9rez JM, Garc\u00eda-Aguirre IA, Murillo-Melo NM, P\u00e9rez-Hern\u00e1ndez N, et al. Integrated Plasma and Glial Cell Evidence Indicates a Functional Role for hsa-miR-342-5p in Spinocerebellar Ataxia Type 7 and Its Potential Use as a Biomarker. Int J Mol Sci. 2026;27:683.","journal-title":"Int J Mol Sci"},{"key":"2050_CR149","first-page":"1","volume":"13","author":"R Su\u00e1rez-S\u00e1nchez","year":"2023","unstructured":"Su\u00e1rez-S\u00e1nchez R, \u00c1vila-Avil\u00e9s RD, Hern\u00e1ndez-Hern\u00e1ndez JM, S\u00e1nchez-Celis D, Azotla-Vilchis CN, G\u00f3mez-Mac\u00edas ER, et al. RNA Foci Formation in a Retinal Glial Model for Spinocerebellar Ataxia Type 7. Life. 2023;13:1\u201318.","journal-title":"Life"},{"key":"2050_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms26115070","volume":"26","author":"R Hanna Al-Shaikh","year":"2025","unstructured":"Hanna Al-Shaikh R, Jansen-West K, Strongosky A, Parrales Z, Dunmore JA, Song Y, et al. Evaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7. Int J Mol Sci. 2025;26:1\u201315.","journal-title":"Int J Mol Sci"},{"key":"2050_CR151","doi-asserted-by":"publisher","unstructured":"Yin J, White J, Khare S, Wu M, Zuberi AR, Gao M et al. Association of cerebellar inflammation and neurodegeneration in a novel spinocerebellar ataxia type 13 mouse model. bioRxiv [Internet]. 2024;2024.10.28.620701. Available from: https:\/\/doi.org\/10.1101\/2024.10.28.620701","DOI":"10.1101\/2024.10.28.620701"},{"key":"2050_CR152","doi-asserted-by":"publisher","unstructured":"Lin CW, Fan CH, Chang YC, Hsieh-Li HM. ERK activation precedes Purkinje cell loss in mice with Spinocerebellar ataxia type 17. Neurosci Lett [Internet]. 2020;738:135337. Available from: https:\/\/doi.org\/10.1016\/j.neulet.2020.135337","DOI":"10.1016\/j.neulet.2020.135337"},{"key":"2050_CR153","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s11064-015-1530-4","volume":"40","author":"ZZ Chen","year":"2015","unstructured":"Chen ZZ, Wang CM, Lee GC, Hsu HC, Wu TL, Lin CW, et al. Trehalose Attenuates the Gait Ataxia and Gliosis of Spinocerebellar Ataxia Type 17 Mice. Neurochem Res. 2015;40:800\u201310.","journal-title":"Neurochem Res"},{"key":"2050_CR154","doi-asserted-by":"publisher","first-page":"9101","DOI":"10.1523\/JNEUROSCI.0111-17.2017","volume":"37","author":"Y Yang","year":"2017","unstructured":"Yang Y, Yang S, Guo J, Cui Y, Tang B, Li XJ, et al. Synergistic toxicity of polyglutamine-expanded TATA-binding protein in glia and neuronal cells: Therapeutic implications for spinocerebellar ataxia 17. J Neurosci. 2017;37:9101\u201315.","journal-title":"J Neurosci"},{"key":"2050_CR155","doi-asserted-by":"publisher","unstructured":"Seki T, Sato M, Kibe Y, Ohta T, Oshima M, Konno A et al. Lysosomal dysfunction and early glial activation are involved in the pathogenesis of spinocerebellar ataxia type 21 caused by mutant transmembrane protein 240. Neurobiol Dis [Internet]. 2018;120:34\u201350. Available from: https:\/\/doi.org\/10.1016\/j.nbd.2018.08.022","DOI":"10.1016\/j.nbd.2018.08.022"},{"key":"2050_CR156","doi-asserted-by":"crossref","unstructured":"Donato R, Sorci G, Bianchi R, Riuzzi F, Tubaro C, Arcuri C et al. S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond. Cardiovasc Psychiatry Neurol. 2010;2010.","DOI":"10.1155\/2010\/656481"},{"key":"2050_CR157","doi-asserted-by":"publisher","unstructured":"Costa RG, Concei\u00e7\u00e3o A, Matos CA, N\u00f3brega C. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease. Cell Death Dis [Internet]. 2024;15:415. Available from: https:\/\/doi.org\/10.1038\/s41419-024-06812-5","DOI":"10.1038\/s41419-024-06812-5"},{"key":"2050_CR158","doi-asserted-by":"publisher","unstructured":"Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, DeJesus-Hernandez M et al. Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet [Internet]. 2011;20:3207\u201312. Available from: https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/https:\/\/doi.org\/10.1093\/hmg\/ddr227","DOI":"10.1093\/hmg\/ddr227"},{"key":"2050_CR159","unstructured":"Arttia Creative. Brain RNA-Seq [Internet]. Available from: https:\/\/www.brainrnaseq.org\/"},{"key":"2050_CR160","doi-asserted-by":"crossref","unstructured":"Han X, Liao R, Li X, Zhang C, Huo S, Qin L et al. Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Signal Transduct Target Ther [Internet]. 2025;10:262. Available from: https:\/\/www.nature.com\/articles\/s41392-025-02313-9","DOI":"10.1038\/s41392-025-02313-9"},{"key":"2050_CR161","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Carralero E, Quinet G, Freire R. ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3. Expert Rev Mol Med [Internet]. 2024;26:e19. Available from: https:\/\/www.cambridge.org\/core\/product\/identifier\/S1462399424000103\/type\/journal_article","DOI":"10.1017\/erm.2024.10"},{"key":"2050_CR162","doi-asserted-by":"publisher","unstructured":"Groh J, Friedman HC, Orel N, Ip CW, Fischer S, Spahn I et al. Pathogenic inflammation in the CNS of mice carrying human PLP1 mutations. Hum Mol Genet [Internet]. 2016;ddw296. Available from: https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/https:\/\/doi.org\/10.1093\/hmg\/ddw296","DOI":"10.1093\/hmg\/ddw296"},{"key":"2050_CR163","doi-asserted-by":"publisher","unstructured":"Niewiadomska-cimicka A, Trottier Y. Molecular targets and therapeutic strategies in spinocerebellar ataxia type 7. Neurotherapeutics. 2019;16(4):1074\u201396. https:\/\/doi.org\/10.1007\/s13311-019-00778-5","DOI":"10.1007\/s13311-019-00778-5"},{"key":"2050_CR164","doi-asserted-by":"publisher","unstructured":"Ahn SH, Jang Y, Jang B-S, Moon J, Lee W-J, Park D-K et al. Multi-omic insights into molecular mechanism and therapeutic targets in spinocerebellar ataxia type 7. Mol Ther Nucleic Acids [Internet]. 2025;36:102414. Available from: https:\/\/doi.org\/10.1016\/j.omtn.2024.102414","DOI":"10.1016\/j.omtn.2024.102414"},{"key":"2050_CR165","doi-asserted-by":"crossref","unstructured":"Liu Q, Pan Y, Li X-J, Li S. Molecular mechanisms and therapeutics for sca17. Neurotherapeutics [Internet]. 2019;16:1097\u2013105. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923009698","DOI":"10.1007\/s13311-019-00762-z"},{"key":"2050_CR166","doi-asserted-by":"publisher","unstructured":"Delplanque J, Devos D, Huin V, Genet A, Sand O, Moreau C et al. TMEM240 mutations cause spinocerebellar ataxia 21 with mental retardation and severe cognitive impairment. Brain [Internet]. 2014;137:2657\u201363. Available from: https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/https:\/\/doi.org\/10.1093\/brain\/awu202","DOI":"10.1093\/brain\/awu202"},{"key":"2050_CR167","doi-asserted-by":"crossref","unstructured":"Beltran-Velasco AI, Clemente-Su\u00e1rez VJ. Impact of peripheral inflammation on blood\u2013brain barrier dysfunction and its role in neurodegenerative diseases. Int J Mol Sci [Internet]. 2025;26:2440. Available from: https:\/\/www.mdpi.com\/1422-0067\/26\/6\/2440","DOI":"10.3390\/ijms26062440"},{"key":"2050_CR168","doi-asserted-by":"publisher","unstructured":"Duarte Lobo D, Nobre RJ, Oliveira Miranda C, Pereira D, Castelhano J, Sereno J et al. The blood-brain barrier is disrupted in Machado-Joseph disease\/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples. Acta Neuropathol Commun [Internet]. 2020;8:152. Available from: https:\/\/actaneurocomms.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s40478-020-00955-0","DOI":"10.1186\/s40478-020-00955-0"},{"key":"2050_CR169","doi-asserted-by":"publisher","unstructured":"Liu Y, Xiong F, Liu Q, Wang W, Xie T, Duan Y et al. Altered glymphatic network in spinocerebellar ataxia: a multimodal mri study within a structure\u2013environment\u2013function framework. The Cerebellum [Internet]. 2026;25:7. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12311-025-01951-7","DOI":"10.1007\/s12311-025-01951-7"},{"key":"2050_CR170","doi-asserted-by":"crossref","unstructured":"Xia X-Y, Huang Z-Q, Lin H-H, Liu Z-Y, Zhang L, Li M-C et al. Diffusion along perivascular spaces as a marker for Glymphatic system impairment in spinocerebellar Ataxia type 3. Neurobiol Dis [Internet]. 2026;218:107232. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125004498","DOI":"10.1016\/j.nbd.2025.107232"},{"key":"2050_CR171","doi-asserted-by":"crossref","unstructured":"Silwedel C, F\u00f6rster C. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli. J Neuroimmunol [Internet]. 2006;179:37\u201345. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572806002542","DOI":"10.1016\/j.jneuroim.2006.06.019"},{"key":"2050_CR172","doi-asserted-by":"publisher","unstructured":"Priovoulos N, Bazin P-L, Brouwer EJP, Mejias JF, de Buck MHS, Alkemade A et al. Mesoscale imaging of the human cerebellum reveals converging regional specialization of its morphology, vasculature, and cytoarchitecture. Proc Natl Acad Sci [Internet]. 2026;123. Available from: https:\/\/doi.org\/10.1073\/pnas.2516608123","DOI":"10.1073\/pnas.2516608123"},{"key":"2050_CR173","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/10738584211024907","volume":"28","author":"D Dressman","year":"2022","unstructured":"Dressman D, Elyaman WT, Cells. A Growing Universe of Roles in Neurodegenerative Diseases. Neuroscientist. 2022;28:335\u201348.","journal-title":"Neuroscientist"},{"key":"2050_CR174","doi-asserted-by":"publisher","unstructured":"DeMaio A, Mehrotra S, Sambamurti K, Husain S. The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases. J Neuroinflammation [Internet]. 2022;19:1\u201319. Available from: https:\/\/doi.org\/10.1186\/s12974-022-02605-9","DOI":"10.1186\/s12974-022-02605-9"},{"key":"2050_CR175","doi-asserted-by":"publisher","unstructured":"Kim K, Wang X, Ragonnaud E, Bodogai M, Illouz T, DeLuca M et al. Therapeutic B-cell depletion reverses progression of Alzheimer\u2019s disease. Nat Commun [Internet]. 2021;12:1\u201311. Available from: https:\/\/doi.org\/10.1038\/s41467-021-22479-4","DOI":"10.1038\/s41467-021-22479-4"},{"key":"2050_CR176","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13195-025-01791-x","volume":"17","author":"A Faridar","year":"2025","unstructured":"Faridar A, Gamez N, Li D, Wang Y, Boradia R, Thome AD, et al. Low \u2013 dose interleukin \u2013 2 in patients with mild to moderate Alzheimer \u2019 s disease: a randomized clinical trial. Alzheimer\u2019s Res Ther. 2025;17:146.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"2050_CR177","doi-asserted-by":"crossref","unstructured":"Bakthavachalu B, Huelsmeier J, Sudhakaran IP, Hillebrand J, Singh A, Petrauskas A et al. RNP-granule assembly via ataxin-2 disordered domains is required for long-term memory and neurodegeneration. Neuron [Internet]. 2018;98:754\u2013766.e4. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627318303404","DOI":"10.1016\/j.neuron.2018.04.032"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02050-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-026-02050-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02050-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:10:14Z","timestamp":1786165814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-026-02050-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":177,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2050"],"URL":"https:\/\/doi.org\/10.1007\/s12311-026-02050-x","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work did not generate any data sets as it was a review. No experimental data were collected or analyzed.","order":3,"name":"Ethics","label":"Data sharing statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors received funding from the Cuban Ministry of Science, Technology and Environment. None has received any other funding for the last 12 months relevant or not for this manuscript.","order":5,"name":"Ethics","label":"Financial Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"108"}}